Plains GP (NYSE:PAGP – Get Rating) had its price target lifted by equities researchers at Morgan Stanley from $16.00 to $17.00 in a research report issued on Tuesday, The Fly reports. Morgan Stanley’s price objective indicates a potential upside of 25.09% from the stock’s current price. A number of other brokerages have also recently issued […]